Revenue breakdown: Domestic Operations (56.1%), International Operations (43.9%).
8-K
Kewaunee Scientific Corporation announced Q3 FY2026 results with sales of $69,399,000 (up 3.3% YoY), pre-tax earnings of $1,604,000 (up 25.8% YoY), but net earnings declined to $692,000 from $1,354,000 YoY due to seasonal factors and integration costs. Order backlog stood at $183.2 million as of January 31, 2026.